Quick Answer
BICYCLE THERAPEUTICS PLC reported Diluted EPS of $3.16 per share (loss) for fiscal year 2025.
BICYCLE THERAPEUTICS PLC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$3.16 | -9.0% |
| 2024 | -$2.90 | +42.9% |
| 2023 | -$5.08 | -33.7% |
| 2022 | -$3.80 | -42.3% |
| 2021 | -$2.67 | -0.4% |
| 2020 | -$2.66 | +4.0% |
| 2019 | -$2.77 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.85 | -14.9% | +25.4% |
| June 30, 2025 | -$1.14 | -48.1% | -29.5% |
| March 31, 2025 | -$0.88 | -41.9% | -18.9% |
| September 30, 2024 | -$0.74 | +41.3% | +3.9% |
| June 30, 2024 | -$0.77 | +45.4% | -24.2% |
| March 31, 2024 | -$0.62 | +52.3% | +50.8% |
| September 30, 2023 | -$1.26 | -31.3% | +10.6% |
| June 30, 2023 | -$1.41 | -56.7% | -8.5% |
- BICYCLE THERAPEUTICS PLC showed a decrease of -9.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, BICYCLE THERAPEUTICS PLC’s diluted eps has declined by 14.1% (from $2.77 per share (loss) to $3.16 per share (loss)).
- The most recent figure is from BICYCLE THERAPEUTICS PLC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: